SCHEMBL21453034

SCHEMBL21453034

Cc1nc(-c2ccc(OC(F)(F)F)cc2)cc(N2CCC[C@@H](F)C2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.47
▸ DGAT2 Q96PD7 1/20 0.40
▸ USP30 Q70CQ3 1/20 0.39
▸ GABBR2 O75899 1/20 0.39
▸ GABBR1 Q9UBS5 1/20 0.39
▸ GALR2 O43603 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MAP3K12 Q12852 4/20 0.38
▸ ABL1 P00519 2/20 0.38
▸ PIM1 P11309 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ MGAT2 Q10469 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ACP1 P24666 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452934 0.87 KMT2A (0.42) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL21434101 0.85 KMT2A (0.61) KMT2AGALR2KDM4EALDH1A1HPGD
SCHEMBL21452862 0.80 KMT2A (0.44) KMT2AMAP3K12CHRM3PDE4APDE4B
SCHEMBL21433981 0.78 SMPD3 (0.47) ABL1ADORA3
SCHEMBL21433979 0.78 SMPD3 (0.47) ABL1ADORA3
SCHEMBL21452494 0.78 SMPD3 (0.47) ABL1ADORA3
SCHEMBL21434128 0.77 SCN9A (0.48) KMT2AKDM4EABL1ADORA3PDE4A
SCHEMBL21434136 0.76 CHRM3 (0.53) KMT2AUSP30GALR2KDM4EALDH1A1
SCHEMBL21434029 0.76 SMPD3 (0.55) KMT2AABL1ADORA3
SCHEMBL21433975 0.75 KMT2A (0.41) KMT2AGABBR2GABBR1GALR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback